EQUINOR ASA (EQNR): what the price requires
The current priced-in claim for EQUINOR ASA (EQNR) is temporarily suppressed because the live engine record is unavailable. The dated report remains a snapshot, not a current market read.
Generated: 2026-07-14 · Exported: 2026-07-16 · Source: https://boothcheck.com/report/EQNR
Headline
| Field | Value |
|---|---|
| Ticker | EQNR |
| Company | EQUINOR ASA |
| Current price | $36.08/sh |
What The Price Requires (Inversion)
The assumption today's price embeds, recovered by inverting the valuation.
| Field | Value |
|---|---|
| Inversion basis | whole-company |
| Operating margin needed | 14.9% |
| Operating margin today | 31.5% |
| Margin compression implied | -16.6pp |
| Multiple paid | 3x operating income |
The operating-margin requirement is derived from the framework's value band at year 12, a separately labeled basis from the headline growth/duration solve.
The price sits below what even a 5%/yr operating-profit decline would warrant; the inversion reports a bound, not a solved growth path.
Solve inputs: computed at a 7.3% cost of capital with 4% terminal growth over a 5-year stage.
How unusual the bet is: within-range (limited comparison data)
| Reference | Value |
|---|---|
| vs own history | -0.34σ |
| implied end-window share | 0% |
Valuation X-Ray
Asset, earnings-power and peer-multiple models all land far below the price; ONLY the growth-DCF reaches it. The bet is durable compounding the static frames structurally cannot price (a moat/durability premium).
How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.
| Family | Median price/FV | Models | Reads |
|---|---|---|---|
| Asset | 4.11x | 5 | expensive |
| Earnings | 3.96x | 3 | expensive |
| Relative | 2.69x | 5 | expensive |
| Growth | 0.72x | 2 | justifies |
Families that justify the price: Growth Families that call it expensive: Asset, Earnings, Relative
The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 7.2%); the inversion above states its own rate.
Per-Model Detail (n=15)
| Model | Family | FV | Price/FV | Applicable | Methodology |
|---|---|---|---|---|---|
| DCF Perpetual Growth | Growth | $48.27 | 0.75x | yes | Reference only (OCF-based, capex excluded): OCF $3.2B |
| DCF Exit Multiple | Growth | $0.00 | — | no | Negative/zero FCF or EBITDA — equity value floored at $0 |
| Relative Valuation | Relative | $18.24 | 1.98x | yes | P/E 17.77x (blended: static sector reference 10x + trailing (TTM) 36x), scenarios: 13.3x / 17.8x / 21.3x (bear / base = reference held flat / bull), EV/EBITDA 8.13x |
| Simple DDM | Growth | — | — | no | — |
| Two-Stage DDM | Growth | — | — | no | — |
| Simple Excess Return | Asset | $10.87 | 3.32x | yes | BV/sh $16.03, ROE (TTM) 6.3%, ke 9.3% |
| Two-Stage Excess Return | Asset | $8.77 | 4.11x | yes | 5yr excess ROE then converge to ke=9.3% |
| Discounted Future Market Cap | Growth | $52.35 | 0.69x | yes | Rev $28.3B, growth 30% (input: historical growth; tapered), Terminal P/S: 2.4x / 3.2x / 3.9x (bear / base = today's held flat / bull, cap 6x) |
| Peter Lynch Fair Value | Relative | $10.11 | 3.57x | yes | EPS $0.84, growth 2% (input: historical EPS growth), PEG=17.95 (Overvalued) |
| Margin Trajectory | Growth | — | — | no | — |
| Earnings Power Value | Earnings | $9.04 | 3.99x | yes | Normalized EBIT (3y avg op income, one-time charges added back) $7.03B × (1−26%) / WACC 7.2% → EPV (no growth) |
| Residual Income | Asset | $8.49 | 4.25x | yes | BV $16.03 + 5yr PV of (ROE (TTM) 6.3% − Kₑ 9.3%) × BV; BV grows 4.1%/yr |
| Graham Number | Asset | $17.43 | 2.07x | yes | √(22.5 × EPS $0.84 × BVPS $16.03) — Graham's conservative floor |
| EV/EBITDA Relative | Relative | $5.89 | 6.13x | yes | EBITDA $10.77B × sector EV/EBITDA 6.0x |
| FCF Yield | Earnings | — | — | no | — |
| SBC-Adj FCF Yield | Earnings | — | — | no | — |
| Ben Graham Formula | Earnings | $27.18 | 1.33x | yes | EPS $0.84 × (8.5 + 2×15.0%) × (4.4 / 5.3%) |
| ROIC-Justified P/B | Asset | $2.41 | 14.97x | yes | BV $16.03 × (ROIC 1.1% / WACC 7.2%) |
| P/Sales Sector | Relative | $13.43 | 2.69x | yes | Revenue $28.27B × sector P/S 1.2x |
| PEG Fair Value | Relative | $31.59 | 1.14x | yes | EPS $0.84 × (PEG 1.5 × growth 25.0% (input: historical EPS growth)) → PE 37.5x |
| Earnings Yield | Earnings | $9.11 | 3.96x | yes | EPS $0.84 / required return 9.3% (Rf 4.3% + ERP 5.0%) |
| Funds From Operations Multiple | Relative | — | — | no | — |
| Clinical Phase NPV | Growth | — | — | no | — |
| Merton | Asset | — | — | no | — |
| V5 Mechanical | — | — | — | no | — |
Solvency
| Field | Value |
|---|---|
| Net debt | $10.8b |
| Net debt / NOPAT (after-tax) | 0.41x |
| Net debt / operating income (pre-tax) | 0.30x |
| Share count CAGR (buyback) | -5.7% |
| Burning cash | no |
Interest expense is not separately reported in the latest filings, so interest coverage cannot be computed.
Bullet Takeaways
- Equinor is a low-cost Norwegian energy major and major European gas supplier with an exceptionally light balance sheet, net debt at just 0.3 times operating income, funding a through-cycle capital return while the units trade at only about 2.4 times trailing operating profit.
- The biggest specific risk is commodity cyclicality compounded by a capital-heavy renewables strategy: revenue fell 7% year over year even as production rose, and the U.S. Empire Wind offshore project has faced regulatory delays with the company weighing a stake farm-down and a possible exit from a second phase.
- What to watch next is the oil and gas price environment against roughly $13 billion of committed 2026 capex, the Empire Wind resolution, and continued execution of the up-to-$1.5-billion buyback plan.
Bull Case
Look at where the price sits against the methods and the picture is unusually grounded. On the cash-flow lens the units land below what discounted future profits would support, meaning the price does not even fully credit the forward earnings the business is generating. Equinor produced trailing operating income of roughly $35.6 billion at an operating margin near 31.5%, and the price works out to only about 2.4 times that operating profit. For an integrated energy producer with the lowest leverage in its peer group, that is a price the market is keeping cheap against the cash the business throws off, not a price stretched ahead of it.
The financial position is the quiet strength. Net debt is about $10.8 billion, only 0.3 times trailing operating income, which is a near-pristine balance sheet for an oil and gas major. That cushion is what lets Equinor return cash through the cycle rather than only at the top of it. The board declared a quarterly dividend of $0.39 per share and is running a 2026 buyback plan of up to $1.5 billion, with a second tranche of up to $375 million launched in the first quarter. The share count has been shrinking at roughly a 5.7% annual pace. Pairing a fortress balance sheet with steady buybacks means each remaining share owns a larger slice of the Norwegian production base every year.
The operating momentum is real and recent. First-quarter 2026 net income was $3.11 billion, with production up about 9% year over year on higher liquids and gas volumes, and management held its 2026 outlook for around 3% production growth against roughly $13 billion of organic capital spending. Equinor is also a major European gas supplier at a moment when secure, non-Russian gas commands a strategic premium, and its low-cost Norwegian continental shelf assets sit at the favorable end of the global cost curve. Cheap to operate, lightly levered, growing volumes, and returning cash: the bull case does not need a high oil price to work, it needs the current one to hold.
Bear Case
The disruption Equinor faces is not a single rival product but the slow re-pricing of its entire business model, and the company has chosen to stand on both sides of it. It competes for capital against the U.S. supermajors, ExxonMobil, Chevron, and ConocoPhillips among them, which have leaned harder into low-cost hydrocarbon production, and against pure-play renewables developers on the other side. Equinor's bet is to be an energy company spanning both, and the most visible expression of that, the Empire Wind offshore project off New York, has become a cautionary tale about the economics. The company has signaled it intends to farm down its stake in Empire Wind 1 to reduce exposure, and it is weighing abandoning Empire Wind 2 entirely amid evolving U.S. regulation. A strategy that straddles oil and renewables risks earning the cost of capital of neither: the market prices oil majors for cash return and renewables developers for growth, and a hybrid can fall into the discount between them.
The deeper bear point is the cyclicality the recent results mask. First-quarter net income of $3.11 billion and 9% production growth look strong, but a commodity producer's peak earnings are not its sustainable earnings. Revenue actually fell 7% year over year even as production rose, a reminder that price, not volume, is the swing factor, and price is the one variable Equinor does not control. Roughly $13 billion of annual capital spending is committed against a 2026 production plan, and that capex is locked in regardless of where Brent trades when the barrels arrive. A sustained downturn in oil and gas prices compresses the operating margin from today's 31.5% and the cash that funds the dividend and buyback at once.
The valuation honestly reflects this tension rather than denying it. Most of the standard methods, asset value, earnings power, and peer multiples, price the units well above where those frames land, consistent with a market that discounts a producer whose earnings swing with a commodity and whose renewables pivot has consumed capital without yet delivering the returns of its hydrocarbon base. Only the cash-flow lens reaches the price. The cautious tone from the sell side fits: this is a hold-rated name where the debate is about durability of returns, not a discovery of hidden value. The balance sheet, net debt at 0.3 times operating income, means Equinor will survive a downturn comfortably. The bear case is not solvency; it is that a politically exposed, capital-heavy energy transition strategy keeps the multiple low, and a weaker commodity cycle turns today's record cash return into a leaner one.
Valuation
What the price is betting is modest, almost defensive. At roughly 2.4 times trailing operating income, with an operating margin near 31.5%, the units are priced low enough that they sit below what even a gradual decline in operating profit would justify on the cash-flow lens. The market is not asking Equinor to grow into its price; it is pricing in erosion. For a producer that just grew production about 9% and held its outlook for further growth, that embedded assumption is conservative, which is the central observation about the valuation.
The methods disagree in a telling pattern. The asset-value, earnings-power, and peer-multiple lenses all price the units above where those frames land, while the cash-flow lens reaches the price. The right way to read that for a commodity producer is through the cyclical frame: the static methods anchor on a single year's earnings or assets, and for an oil and gas major those figures are inflated or depressed by where the commodity sits in its cycle. Peak earnings are not sustainable earnings, and the market's discount on the static frames is, in effect, the market's refusal to capitalize a top-of-cycle number. The cash-flow lens, which smooths the forward stream, is the one that lands near the price, which is itself the signal that this is a value-and-cash-return name rather than a growth bet.
Solvency is where Equinor separates from most of its sector, and it is the supportive leg of the whole case. Net debt is about $10.8 billion, only 0.3 times trailing operating income, an exceptionally light load for a capital-intensive energy major. That balance sheet funds a through-cycle capital return, a $0.39 quarterly dividend and up to $1.5 billion of buybacks planned for 2026, without leaning on debt, and it lets the company absorb a commodity downturn that would strain more leveraged peers. The most decisive number is not the multiple but the leverage: a producer this cheap on operating income, with this little debt and this much production behind it, is priced for the cycle to turn against it, and the balance sheet says it can wait out the turn.
Catalysts
The Q1 2026 report was the central recent event and it beat on earnings while missing on revenue, a split that tells the cyclical story. Net income was $3.11 billion, with production up roughly 9% year over year on higher liquids and gas volumes, but revenue fell 7% to about $27.8 billion as prices offset the volume gain. The board declared a $0.39 quarterly dividend and launched a second 2026 buyback tranche of up to $375 million, part of a plan for up to $1.5 billion in repurchases this year. Management held the 2026 outlook for around 3% production growth against roughly $13 billion of organic capital spending.
The Empire Wind offshore project is the live regulatory catalyst. Empire Wind 1, an 810 MW project set to be the first offshore wind to connect into the New York City grid, is more than 60% complete and reached financial close, but it faced a stop-work order in early 2026 before Equinor resumed construction under a court injunction. The company has signaled it intends to farm down its stake to reduce exposure and is weighing abandoning a second phase, Empire Wind 2, amid evolving U.S. regulation. How that resolves affects both the renewables capital allocation and the headline risk on the stock.
Into the next several quarters, the events that matter are the commodity-price path, since revenue and cash return move with it more than with volume, the Empire Wind farm-down and any decision on the second phase, and the pace of the buyback. Sell-side positioning is cautious, clustered around a hold view, so a clean Empire Wind resolution or a firmer commodity backdrop would be the more likely sources of a re-rating than a guidance change.
Peer Cohorts (Per Segment, With Filing Citations)
Core business (reported)
- XOM (Exxon Mobil Corporation)
- (no filing in the citation store)
- CVX (Chevron Corp)
- (no filing in the citation store)
- COP (ConocoPhillips)
- (no filing in the citation store)
- SU (SUNCOR ENERGY INC)
- (no filing in the citation store)
- IMO (IMPERIAL OIL LIMITED)
- (no filing in the citation store)
- MPC (MARATHON PETROLEUM CORPORATION)
- (no filing in the citation store)
- PSX (Phillips 66)
- (no filing in the citation store)
- VLO (VALERO ENERGY CORP/TX)
- (no filing in the citation store)
Methodology Note
- Priced-in inversion: the valuation is inverted on the current price to recover the operating-income growth, duration, and steady-state margin the price embeds (ROE for financials, FFO growth for REITs).
- Valuation x-ray: the valuation models, grouped into four families (asset, earnings, relative, growth). Each model is expressed as a price/FV ratio (distance from price), not a point fair-value estimate. The spread across families is the disagreement.
- Solvency: net cash/debt, net-debt-to-NOPAT, interest coverage, and share-count CAGR from EDGAR financials (net debt / FFO and fixed-charge coverage for REITs; regulatory-capital framing for financials).
- Peer cohorts: per-segment comparables with deep-linkable SEC filing citations.
Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.
Sources
Q1 2026 earnings release · company project updates, 2026 · analyst consensus, 2026